top of page

Téléphone : +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Obeda 2mg FlexTouch

Obeda 2mg FlexTouch

Manufacturer/Marketed By : DR REDDY'S LABORATORIES LTD

$44.72 $40.25

Obeda 2mg FlexTouch is a once-weekly injectable treatment used to support effective, sustainable weight management in adults. It contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

SEMAGLUTIDE

Active Pharmaceutical Ingredient

Obeda 2mg FlexTouch

SKU OBEDA-2MG-FLEXTOUCH
Prix d’origine

44,72 $US

Prix promotionnel

40,25 $US

Obeda 2mg FlexTouch is a once-weekly injectable treatment used to support effective, sustainable weight management in adults. It contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation and food intake. One of the key Obeda FlexTouch 2mg benefits is that it helps you feel full sooner and stay satisfied for longer, which supports healthier eating habits and portion control. Due to these effects, Obeda FlexTouch 2mg weight-loss results are often observed when the medication is combined with a balanced diet and regular physical activity. This treatment is commonly recommended for individuals who are overweight or living with obesity, particularly those who also have associated conditions such as type 2 diabetes, high blood pressure, or high cholesterol. While Obeda FlexTouch 2mg is not a rapid solution, it plays an important role in long-term weight management when used consistently and under medical supervision. Your doctor will guide you on the correct Obeda FlexTouch 2mg dosage instructions based on your health profile and treatment goals. Before starting therapy, it is important to consult a healthcare professional who will evaluate your medical history, suitability, and expectations from treatment. Patients may also want to discuss practical aspects such as the Obeda 2mg price and availability as part of their overall treatment planning.

Active Pharmaceutical Ingredient

SEMAGLUTIDE

Uses

• Long-term weight management in adults with obesity (BMI of 30 or more)
• Weight management in adults with a BMI of 27 or more who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Obeda 2mg FlexTouch causes some side effects like all medications, although not everyone will experience them.

Most Common Side Effects

• Severe stomach pain or signs of pancreatitis
• Gallbladder issues (like pain in your upper belly or yellowing of the skin)
• Signs of kidney problems (such as less urination or swelling)
• Fast heart rate
• Allergic reactions (rash, itching, swelling, trouble breathing)

Common Side Effects

• Nausea
• Vomiting
• Constipation or diarrhoea
• Tiredness
• Headache
• Indigestion
• Bloating or gas

How To Use

Obeda 2mg FlexTouch, a GLP-1–based medication, is given once a week as an injection under the skin. You can inject it into your stomach, thigh, or upper arm; just rotate injection sites to avoid irritation. It can be taken with or without food.

Safety Advice

• Pregnancy: Obeda 2mg FlexTouch is not safe during pregnancy. If you're planning to get pregnant, you'll need to stop this medication at least 2 months before trying.
• Breast Feeding: If you are breastfeeding, consult your healthcare provider before using Obeda 2mg FlexTouch, as its efficacy and safety in breastfeeding are unknown.
• Lungs: Obeda 2mg FlexTouch doesn’t directly affect your lungs. If you have asthma or another lung issue, it’s still safe, but your doctor should be in the loop.
• Liver: People with liver issues may still be able to take Obeda 2mg FlexTouch, but some extra care and monitoring might be needed.
• Alcohol: Drinking alcohol while using Obeda 2mg FlexTouch can increase your risk of stomach issues or low blood sugar, especially if you’re diabetic.
• Driving: Obeda 2mg FlexTouch doesn’t usually affect your ability to drive. But if you feel dizzy, tired, or unwell after the shot, skip driving that day.

Disclaimer

Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.

Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.

Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.

Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.

bottom of page